Altamira Therapeutics Ltd. 20-F

Accession 0000950103-17-002421

Filing information

CIK: 0001601936
Report date: 2016-12-31
Filing date: 2017-03-14
Form: 20-F
Primary document: dp73891_20f.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.